Cargando…

“When Treatment Is More Challenging than the Disease”: A Qualitative Study of MDR-TB Patient Retention

BACKGROUND: One-fifth of the patients on multidrug-resistant tuberculosis treatment at the Drug-Resistant-TB (DR-TB) Site in Gujarat are lost-to-follow-up(LFU). OBJECTIVE: To understand patients’ and providers' perspectives on reasons for LFU and their suggestions to improve retention-in-care....

Descripción completa

Detalles Bibliográficos
Autores principales: Shringarpure, Kalpita S., Isaakidis, Petros, Sagili, Karuna D., Baxi, R. K., Das, Mrinalini, Daftary, Amrita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784928/
https://www.ncbi.nlm.nih.gov/pubmed/26959366
http://dx.doi.org/10.1371/journal.pone.0150849
Descripción
Sumario:BACKGROUND: One-fifth of the patients on multidrug-resistant tuberculosis treatment at the Drug-Resistant-TB (DR-TB) Site in Gujarat are lost-to-follow-up(LFU). OBJECTIVE: To understand patients’ and providers' perspectives on reasons for LFU and their suggestions to improve retention-in-care. DESIGN: Qualitative study conducted between December 2013-March 2014, including in-depth interviews with LFU patients and DOT-providers, and a focus group discussion with DR-TB site supervisors. A thematic-network analysis approach was utilised. RESULTS: Three sub-themes emerged: (i) Struggle with prolonged treatment; (ii) Strive against stigma and toward support; (iii) Divergent perceptions and practices. Daily injections, pill burden, DOT, migratory work, social problems, prior TB treatment, and adverse drugs effects were reported as major barriers to treatment adherence and retention-in-care by patients and providers. Some providers felt that despite their best efforts, LFU patients remain. Patient movements between private practitioners and traditional healers further influenced LFU. CONCLUSION: The study points to a need for repeated patient counselling and education, improved co-ordination between various tiers of providers engaged in DR-TB care, collaboration between the public, private and traditional practitioners, and promotion of social and economic support to help patients adhere to MDR-TB treatment and avoid LFU.